Figure 15.Prognostic analysis of FANCE in multiple cancers. (A) For cervical squamous cell carcinoma, high expression of FANCE is associated with good prognosis (*P<0.001). (B) In esophageal squamous cell carcinoma patients, up-regulated expression of FANCE is associated with good prognosis (*P=0.035); (C) For gastric cancer, increased expression of FANCE is associated with better prognosis (*P=0.014); (D) For lung squamous cell carcinoma, up-regulated expression of FANCE predicts improved prognosis (*P=4.7×10-3); (E) For rectal adenocarcinoma, increased expression of FANCE is associated with better prognosis (*P=0.045).
